NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease

INTRODUCTION: BrainAge models based on neuroimaging data have diagnostic classification power but have replicability issues due to site and patient variability. BrainAge models trained on neuropsychological tests could help distinguish stable mild cognitive impairment (sMCI) from progressive MCI (pM...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia Condado, Jorge, Cortes, Jesus M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614125/
https://www.ncbi.nlm.nih.gov/pubmed/37908437
http://dx.doi.org/10.1002/dad2.12493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614125/
https://www.ncbi.nlm.nih.gov/pubmed/37908437
http://dx.doi.org/10.1002/dad2.12493

Ejemplares similares